A Singapore Government Agency Website 

Who should receive an additional dose in 2024?



An additional dose of vaccine to be administered around 1 year (and no earlier than 5 months) after the last dose received to keep up-to-date with COVID-19 vaccination. The additional dose is:


  • Recommended for all persons aged 60 years and above, medically vulnerable individuals and residents of aged care facilities;

  • Encouraged for all individuals aged 6 months and above, in particular, healthcare workers, as well as household members and caregivers of medically vulnerable individuals.


The Pfizer-BioNTech/Comirnaty and Moderna/Spikevax vaccines are recommended for this. Those who are medically ineligible for mRNA vaccines may receive Novavax/Nuvaxovid or Sinovac-CoronaVac^ as an alternative.


Note: Age eligibility for the various vaccines apply. Under the National Vaccination Programme, persons aged 6 months to 11 years are eligible to receive the Pfizer-BioNTech/Comirnaty and Moderna/Spikevax vaccines. Persons aged 12-17 years are eligible to receive the Pfizer-BioNTech/Comirnaty, Moderna/Spikevax or Novavax/Nuvaxovid vaccines. Persons aged 18 years and older are eligible to receive the Pfizer-BioNTech/Comirnaty, Moderna/Spikevax, Novavax/Nuvaxovid or Sinovac-CoronaVac^ vaccines.


^Sinovac-CoronaVac vaccine continues to be included under the National Vaccination Programme (NVP). However, if there is no application for Sinovac-CoronaVac vaccine to be fully registered, NVP will lapse for Sinovac-CoronaVac vaccine, by 30 September 2024. Nevertheless, Sinovac-CoronaVac vaccine will continue to be available at private clinics which have applied to use it under the Special Access Route (SAR).

Let other citizens know if this answer was helpful
Did this answer your question?

Can’t find what you’re looking for?